Furosemide Analogues Inhibit Aβ Aggregation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapies lack effective compounds to arrest or reverse amyloid formation, deposition, and neuroinflammation associated with Alzheimer's disease, which are critical for treating the disease effectively.
Innovation Solution
Development of furosemide analogues, specifically compounds of Formula Z, which inhibit Aβ aggregation and reduce neuroinflammation by interacting with Aβ misfolding and targeting inflammatory pathways.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional therapies are used for Alzheimer's disease, then current treatment options are available, but they fail to effectively arrest or reverse amyloid formation, deposition, and neuroinflammation
Solution Approach 1:
The patent applies parameter changes by systematically modifying the chemical structure of furosemide through variations in R1, R2, R3, R4, R5, and R6 substituents to optimize the compound's ability to inhibit Aβ aggregation and reduce neuroinflammation, thereby improving therapeutic effectiveness while maintaining the core mechanism of action
Solution Approach 2:
The patent creates composite therapeutic compounds by combining the furosemide core structure with various functional groups and substituents that provide dual activity against both amyloid aggregation and neuroinflammation, resulting in a multi-functional therapeutic agent that addresses multiple pathological mechanisms simultaneously
2Reliability
If new compounds are developed to target Aβ aggregation and neuroinflammation, then therapeutic effectiveness is improved, but the complexity of compound structure and synthesis increases
Solution Approach 1:
The patent segments the therapeutic function into distinct molecular components: the furosemide core structure provides the base pharmacological activity, while separate substituent groups (R1-R6) provide specific functions for Aβ binding and anti-inflammatory activity, allowing independent optimization of each functional element
Solution Approach 2:
The patent designs the furosemide analogue compounds to perform multiple therapeutic functions simultaneously: inhibiting Aβ oligomerization, preventing fibrillization, and reducing neuroinflammatory cytokine production, thereby achieving multi-functionality within a single compound structure that reduces the need for multiple separate medications
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The furosemide analogues demonstrate potent activity in inhibiting Aβ oligomerization and fibrillization, rescuing neuronal cells from neurotoxicity, and reducing inflammatory cytokines, providing a therapeutic approach to prevent or treat Alzheimer's disease.
Implementation Method 1
compounds of Formula Z... which inhibit Aβ aggregation and reduce neuroinflammation by interacting with Aβ misfolding
Implementation Method 2
rescuing neuronal cells from neurotoxicity, and reducing inflammatory cytokines
Data Source
AI summary
The present application provides furosemide analogues of the general formula Z having activity as anti-Aβ aggregation agents and/or as inhibitors of Aβ induced neuroinflammation.These compounds are useful in preventing, delaying and/or treating Alzheimer's Disease. Accordingly, the present application further provides pharmaceutical compositions and method for preventing, delaying and/or treating Alzheimer's Disease.